Cyclooxygenase-2 (COX-2) immunostaining does not correlate with the degree of vulvar neoplasia (Q47594688)

4 February 2018

title

Cyclooxygenase-2 (COX-2) immunostaining does not correlate with the degree of vulvar neoplasia (English)

1 reference

4 February 2018

author name string

Sharon Nofech-Mozes

1

1 reference

4 February 2018

Rachel Kupets

2

1 reference

4 February 2018

Golnar Rasty

3

1 reference

4 February 2018

Nadia Ismiil

4

1 reference

4 February 2018

Allan Covens

5

1 reference

4 February 2018

Mahmoud A Khalifa

6

1 reference

4 February 2018

publication date

1 April 2006

1 reference

4 February 2018

Journal of Obstetrics and Gynaecology Canada

published in

1 reference

4 February 2018

volume

28

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

290-294

1 reference

4 February 2018

Vulvar squamous cell carcinoma: guidelines for early diagnosis and treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-2--10 years later

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

The Role of Cyclooxygenase-2 in Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cancer and cyclooxygenase-2 (COX-2) inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-2 expression in borderline ovarian tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Expression of cyclooxygenase 2 by prostaglandin E(2) in human endometrial adenocarcinoma cell line HEC-1B.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Immunohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932134-X

7 January 2021

10.1016/S1701-2163(16)32134-X

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018